Drugs logo Adis International logo

Publisher: Adis International

Related content
Volume 72, Number 14, 1 October 2012

< previous issue | all issues | next issue >

Current Opinion

Interferon-Free Hepatitis C Therapy: How Close Are We?
pp. 1825-1831(7)
Author: Pockros, Paul J.

Thrombolytic Therapy for Acute Ischaemic Stroke: What Can We Do to Improve Outcomes?
pp. 1833-1845(13)
Authors: Demchuk, Andrew M.; Bal, Simerpreet

Review Articles

Opioid-Induced Bowel Dysfunction: Pathophysiology and Management
pp. 1847-1865(19)
Authors: Brock, Christina; >Søren Schou Olesen,; >Anne Estrup Olesen,; Frøkjaer, Jens Brøndum; Andresen, Trine; >Asbjørn Mohr Drewes,

Current and Emerging Systemic Treatment Strategies for Psoriasis
pp. 1867-1880(14)
Authors: Laws, Philip M.; Young, Helen S.

Sedation for Critically Ill or Injured Adults in the Intensive Care Unit: A Shifting Paradigm
pp. 1881-1916(36)
Authors: Roberts, Derek J.; Haroon, Babar; Hall, Richard I.

Adis Drug Profile

Nomegestrol Acetate/Estradiol: In Oral Contraception
pp. 1917-1928(12)
Authors: Yang, Lily P.H.; Plosker, Greg L.

Adis Drug Evaluation

Erratum

Erratum
pp. 1951-1951(1)

< previous issue | all issues | next issue >

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page